News
AK112-311/HARMONi-9 study is the eighth registrational Phase III clinical trial for ivonescimab in lung cancer (including three international multicenter studies). The initiation of this trial further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback